✦ LIBER ✦

Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer

✍ Scribed by Shinsuke Suzuki; Kazuo Ishikawa

Book ID: 106287508
Publisher: Springer
Year: 2009
Tongue: English
Weight: 217 KB
Volume: 15
Category: Article
ISSN: 1341-321X
DOI: 10.1007/s10156-009-0712-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OP0012 Chemotherapy with gefitinib in re

OP0012 Chemotherapy with gefitinib in recurrent and metastatic head and neck cancer

✍ Gupta, D.; Rao, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Oral Metronomic Chemotherapy in Recurren

Oral Metronomic Chemotherapy in Recurrent, Metastatic and Locally Advanced Head and Neck Cancers

✍ Patil, V.; Noronha, V.; Krishna, V.; Joshi, A.; Prabhash, K. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Chemotherapy improves symptoms in recurr

Chemotherapy improves symptoms in recurrent head and neck cancer

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 168 KB

The efficacy and toxicity of S-1 and cis

The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma

✍ Han Sang Kim, Hye Ryun Kim, Gun Min Kim… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 197 KB

Efficacy and safety of weekly paclitaxel

Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients

✍ Jiménez, Begoña; Trigo, José M.; Pajares, Bella I.; Sáez, Maria I.; Quero, Crist 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 509 KB

Phase I/II study of S-1 combined with ca

Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy

✍ Akihito Watanabe; Masanobu Taniguchi; Tetsuro Yamashita; Michihiro Ueda; Tatsuya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background. The aims of this study were to determine the recommended dose (RD) in combination chemotherapy of S‐1 and carboplatin in recurrent and/or metastatic head and neck cancer (phase I) and to examine response rate and toxicities at RD (phase II). ## Methods. S‐1 was given o